Rodrigo Ruiz Soto
Hoofd Techniek/Wetenschap/O&O bij DECIPHERA PHARMACEUTICALS, INC.
Oorsprong van het eerstegraads netwerk van Rodrigo Ruiz Soto
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 28 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rodrigo Ruiz Soto via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chief Executive Officer | |
| Access Industries LLC | Corporate Officer/Principal | ||
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor | |
| Colgate University | College/University | Undergraduate Degree | |
| University of London | College/University | Undergraduate Degree Doctorate Degree | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of New Hampshire | College/University | Doctorate Degree Undergraduate Degree | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Founder Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
University of Kansas Center for Research, Inc.
 University of Kansas Center for Research, Inc. Miscellaneous Commercial ServicesCommercial Services University of Kansas Center for Research, Inc. develops and administrates sponsored university programs. The not-for-profit research foundation submits proposals for external support of research, instructional, and service projects. It also provides contract negotiation, proposal and post-award, facility construction and development, resources investment, and financial management support services. The company was founded in 1962 and is headquartered in Lawrence, KS. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Oncology Clinical Research & Development | Director/Board Member | ||
| IGNYTA INC | Biotechnology | Director/Board Member Director/Board Member | |
| Warner-Lambert Co. LLC | Corporate Officer/Principal | ||
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Halda Therapeutics LLC
 Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Jamanda Ltd. is an investment holding British company founded in 2016. The private company is based in Grantham, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
| Halda Therapeutics OpCo, Inc. | Director/Board Member | ||
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Protypia, Inc.
 Protypia, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Inotiv, Inc., Protypia, Inc. provides targeted tissue-based protein and peptide mass spectrometry solutions. The company is based in Nashville, TN. The company was founded in 2017 by Daniel C. Liebler. Daniel C. Liebler has been the CEO since 2017. Protypia was acquired by Inotiv, Inc. on July 07, 2022 for $11 million. | Miscellaneous Commercial Services | Director/Board Member | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 143 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 48 |
| Chief Executive Officer | 26 |
| Undergraduate Degree | 24 |
Sterkste connecties
| Insiders | |
|---|---|
| Michael Ross | 44 |
| Liam Ratcliffe | 32 |
| Edward Benz | 29 |
| Susan Kelley | 22 |
| James Bristol | 17 |
| Matthew Sherman | 16 |
| Patricia Allen | 14 |
| Michael Taylor | 14 |
| John Martin | 13 |
| Rajesh Devraj | 12 |
| Steven Hoerter | 12 |
| Daniel Flynn | 11 |
| Tucker Kelly | 10 |
| Ron Squarer | 10 |
| Christopher J. Morl | 9 |
- Beurs
- Insiders
- Rodrigo Ruiz Soto
- Bedrijfsconnecties
